Cargando…
Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options
BACKGROUND: Recent studies have shown that breast cancer subtype can change from the primary tumour to the recurrence. Discordance between primary and recurrent breast cancer has implications for further treatment and ultimately prognosis. The aim of the study was to determine the rate of change bet...
Autores principales: | McAnena, Peter F., Brown, James AL, Ramli, A., Curran, C., Malone, C., McLaughlin, R., Barry, K., JAL, Brown, Kerin, M. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819681/ https://www.ncbi.nlm.nih.gov/pubmed/29463223 http://dx.doi.org/10.1186/s12885-018-4101-7 |
Ejemplares similares
-
Correction to: Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options
por: McAnena, Peter F., et al.
Publicado: (2018) -
Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer
por: McAnena, Peter, et al.
Publicado: (2017) -
Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer
por: McAnena, Peter, et al.
Publicado: (2019) -
Differential impact of hormone receptor status on survival and recurrence for HER2 receptor-positive breast cancers treated with Trastuzumab
por: McGuire, Andrew, et al.
Publicado: (2017) -
Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer – A retrospective cohort study
por: Davey, Matthew G., et al.
Publicado: (2021)